BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
61.12
+0.55 (0.91%)
At close: Mar 6, 2026, 4:00 PM EST
61.37
+0.25 (0.41%)
After-hours: Mar 6, 2026, 5:34 PM EST
BioMarin Pharmaceutical Analyst Ratings
Total Analysts
16
Consensus Rating
Buy
Price Target
$87.38
Upside
+42.96%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $80 → $105 | Buy | Maintains | $80 → $105 | +71.79% | Mar 4, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $55 | Hold | Reiterates | $55 | -10.01% | Mar 2, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $98 → $104 | Strong Buy | Maintains | $98 → $104 | +70.16% | Feb 26, 2026 |
| Bernstein | Bernstein | Buy Maintains $90 → $94 | Buy | Maintains | $90 → $94 | +53.80% | Feb 25, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $106 → $86 | Strong Buy | Maintains | $106 → $86 | +40.71% | Feb 25, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $60 → $55 | Hold | Maintains | $60 → $55 | -10.01% | Feb 25, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $98 → $95 | Buy | Maintains | $98 → $95 | +55.43% | Feb 24, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $70 → $75 | Buy | Maintains | $70 → $75 | +22.71% | Feb 18, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $122 → $84 | Buy | Maintains | $122 → $84 | +37.43% | Feb 6, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold → Strong Buy Upgrades $84 → $98 | Hold → Strong Buy | Upgrades | $84 → $98 | +60.34% | Jan 20, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $80 → $100 | Strong Buy | Maintains | $80 → $100 | +63.61% | Dec 23, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $55 → $60 | Hold | Maintains | $55 → $60 | -1.83% | Dec 22, 2025 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $82 → $60 | Buy → Hold | Downgrades | $82 → $60 | -1.83% | Dec 3, 2025 |
| Stifel | Stifel | Strong Buy → Hold Downgrades $73 → $61 | Strong Buy → Hold | Downgrades | $73 → $61 | -0.20% | Nov 6, 2025 |
| Bernstein | Bernstein | Buy Maintains $95 → $88 | Buy | Maintains | $95 → $88 | +43.98% | Nov 3, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $90 → $80 | Strong Buy | Maintains | $90 → $80 | +30.89% | Oct 28, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.